Filter By Industry
Filter By Tag

Newsroom

ReStem Biotech Press releases

1 - 7 of 7 Press Releases

Dec 11, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, today announced that it..

Nov 01, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, today announced that...

Sep 19, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, has recently been...

Aug 22, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, today announced the...

May 15, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, spinal cord injury and cancer, today announced a Grand Opening..

Apr 02, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, spinal cord injury and cancer, sponsored the Guangdong Private..

Feb 25, 2019
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products, including osteoarthritis, spinal cord injury and various cancers today announced that Wutian Wu, PhD, Clinical...


ReStem Biotech RSS Feed